A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs

Addiction. 2025 Feb;120(2):207-208. doi: 10.1111/add.16647. Epub 2024 Aug 12.

Author

Michael P Bogenschutz^{1

2}

Affiliations

¹ Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
² NYU Langone Center for Psychedelic Medicine, New York, NY, USA.

PMID: 39129581
DOI: 10.1111/add.16647

No abstract available

Keywords: MDMA; harm reduction; health policy; pharmacotherapy; psilocybin; psychedelics.